Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Ciputra Development Tbk (CTRA) vs Tempo Scan Pacific Tbk. (TSPC)

Ciputra Development TbkTrading
Tempo Scan Pacific Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Ciputra Development Tbk dan Tempo Scan Pacific Tbk.: Ciputra Development Tbk diperdagangkan di Rp610 (kapitalisasi pasar 11,12 T, volume 24 jam 9,9 jt), sedangkan Tempo Scan Pacific Tbk. diperdagangkan di Rp2.790 (kapitalisasi pasar 12,58 T, volume 24 jam 809,6 rb). Perbedaan utamanya: Ciputra Development Tbk dan Tempo Scan Pacific Tbk. berukuran mirip dari sisi kapitalisasi pasar, dan Ciputra Development Tbk lebih aktif diperdagangkan (9,9 jt vs 809,6 rb). Mana yang lebih baik tergantung tujuan investasimu.

CTRATSPC
Kapitalisasi Pasar
11,12 T12,58 T
Volume
9,9 jt809,6 rb
Lot
99,04 rb8,1 rb
Perputaran
6 M2,26 M
Harga Rata-rata
605,622.786,16
Nilai Transaksi
6 M2,26 M
Harga Ekuilibrium Indikatif
6102.790
Volume Ekuilibrium Indikatif
8,25 rb1,63 rb

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

CTRA
Lihat detail
TSPC
Lihat detail

Tentang Ciputra Development Tbk

PT Ciputra Development Tbk (the Company) was established in the Republic of Indonesia originally under the name PT Citra Habitat Indonesia based on notarial deed No. 22 dated October 22, 1981. Ciputra Developments main interest is in residential and township developments which account for approximately 90% of the companies total sales. The company has nine flagship development projects.

Selengkapnya di halaman CTRA

Tentang Tempo Scan Pacific Tbk.

PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.

Selengkapnya di halaman TSPC